MWM
IMNM icon

Maltin Wealth Management’s Immunome IMNM Stock Holding History

Maltin Wealth Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Sell
9,365
-5,635
-38% -$140K 0.07% 149
2026
Q2 		$318K Hold
15,000
– – 0.11% 110
2026
Q1 		$328K Buy
+15,000
New +$334K 0.13% 99

Other funds holding IMNM

GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Maltin Wealth Management's IMNM Position: Q3 2026 in Review

Maltin Wealth Management reduced its Immunome (IMNM) stake by 38% in Q3 2026, selling an estimated $140K and leaving 9,365 shares worth $201K. The position accounts for 0.07% of the portfolio, ranked #149.

Maltin Wealth Management first reported a position in IMNM in Q1 2026 and has held it in 3 quarters since. The position peaked at $328K in Q1 2026. 6 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Maltin Wealth Management held 9,365 shares of Immunome worth $201K as of Q3 2026.
  • Maltin Wealth Management sold 5,635 Immunome shares in Q3 2026, an estimated $140K.
  • Immunome made up 0.07% of Maltin Wealth Management's portfolio in Q3 2026, its #149 holding.
  • Maltin Wealth Management first reported a position in Immunome in Q1 2026 and has held it in 3 quarters since.
  • Maltin Wealth Management's Immunome position peaked at $328K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Maltin Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.